NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference      

Rhea-AI Summary

MOUNTAIN VIEW, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference. Management will present on September 13 at 12:20 p.m. Eastern Time. The event will be accessible via a live webcast and archived for at least 90 days on the company’s website.

NeuroPace focuses on transforming the lives of epilepsy patients with its RNS System, the first brain-responsive platform for real-time treatment, aiming to improve outcomes for those with drug-resistant epilepsy.

MOUNTAIN VIEW, Calif. , Aug. 23, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference. Management is scheduled to present on Tuesday, September 13 at 12:20 p.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com. The webcasts will be archived and available for replay for at least 90 days after the event

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Gilmartin Group
Emma Poalillo
investors@neuropace.com  

 

FAQ

When will NeuroPace be presenting at the Morgan Stanley Healthcare Conference?

NeuroPace will present on September 13, 2022, at 12:20 p.m. Eastern Time.

How can I watch NeuroPace's presentation at the conference?

You can watch NeuroPace's presentation live or access the archived recording on their Investors section of the website.

What is the focus of NeuroPace's RNS System?

The RNS System focuses on providing personalized, real-time treatment for epilepsy, specifically targeting drug-resistant seizures.

Where is NeuroPace located?

NeuroPace is based in Mountain View, California.

What type of company is NeuroPace?

NeuroPace is a commercial-stage medical device company specializing in innovative treatments for epilepsy.